These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30993311)

  • 1. Dermatomyositis and MIG.
    Ragusa F
    Clin Ter; 2019; 170(2):e142-e147. PubMed ID: 30993311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermatomyositis and chemokines.
    Elia G
    Clin Ter; 2015; 166(2):e118-21. PubMed ID: 25945444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MIG Chemokine in Inflammatory Myopathies.
    Paparo SR
    Clin Ter; 2019; 170(1):e55-e60. PubMed ID: 30789198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcoidosis and the Th1 chemokine MIG.
    Ragusa F
    Clin Ter; 2018; 169(6):e308-e313. PubMed ID: 30554254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MIG in Cutaneous Systemic Lupus Erythematosus.
    Ruffilli I
    Clin Ter; 2019; 170(1):e71-e76. PubMed ID: 30789201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatoid arthritis and the Th1 chemokine MIG.
    Paparo SR
    Clin Ter; 2019; 170(6):e472-e477. PubMed ID: 31696912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MIG Th1 chemokine in Vitiligo.
    Elia G
    Clin Ter; 2018; 169(6):e303-e307. PubMed ID: 30554253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine monokine induced by IFN-gamma/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production.
    Whiting D; Hsieh G; Yun JJ; Banerji A; Yao W; Fishbein MC; Belperio J; Strieter RM; Bonavida B; Ardehali A
    J Immunol; 2004 Jun; 172(12):7417-24. PubMed ID: 15187119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Th1 chemokine MIG in Graves' ophthalmopathy.
    Gonnella D
    Clin Ter; 2019; 170(5):e368-e372. PubMed ID: 31612195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 1 diabetes and MIG.
    Gonnella D
    Clin Ter; 2019; 170(6):e465-e471. PubMed ID: 31696911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL9 chemokine in ulcerative colitis.
    Elia G; Guglielmi G
    Clin Ter; 2018; 169(5):e235-e241. PubMed ID: 30393811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies.
    De Paepe B; De Keyzer K; Martin JJ; De Bleecker JL
    Acta Neuropathol; 2005 Jun; 109(6):576-82. PubMed ID: 15937690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MIG in Crohn's disease.
    Caruso C
    Clin Ter; 2019; 170(3):e206-e210. PubMed ID: 31173051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mig chemokine in primary biliary cirrhosis.
    Mazzi V
    Clin Ter; 2019; 170(3):e211-e215. PubMed ID: 31173052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcoidosis and the alpha chemokine MIG.
    Giusti C
    Clin Ter; 2020; 171(2):e161-e166. PubMed ID: 32141489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.
    Ogawa N; Ping L; Zhenjun L; Takada Y; Sugai S
    Arthritis Rheum; 2002 Oct; 46(10):2730-41. PubMed ID: 12384933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sjögren syndrome and MIG.
    Ruffilli I
    Clin Ter; 2019; 170(6):e478-e482. PubMed ID: 31696913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Th1 chemokines in ulcerative colitis.
    Ragusa F
    Clin Ter; 2015; 166(2):e126-31. PubMed ID: 25945446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypersensitivity pneumonitis and alpha-chemokines.
    Limongi F; Fallahi P
    Clin Ter; 2017; 168(2):e140-e145. PubMed ID: 28383627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin displaces interferon-gamma-inducible chemokines (IP-10, I-TAC, and Mig) sequestered in the vasculature and inhibits the transendothelial migration and arterial recruitment of T cells.
    Ranjbaran H; Wang Y; Manes TD; Yakimov AO; Akhtar S; Kluger MS; Pober JS; Tellides G
    Circulation; 2006 Sep; 114(12):1293-300. PubMed ID: 16940188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.